KalVista launched Ekterly in the U.S. in July for the treatment of acute attacks of hereditary angioedema in adults and ...

Patients with hereditary angioedema using deucrictibant as an on-demand treatment for attacks achieved onset of symptom ...

Hereditary angioedema (HAE) is a serious, potentially fatal disease of recurrent swelling of various subcutaneous and submucosal tissues throughout the body. Swelling is mediated by uncontrolled ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today provided its preliminary fourth quarter and full year ended December 31, ...

Please provide your email address to receive an email when new articles are posted on . The patient, aged 66 years, had no previous edema. The patient tested positive for a mutation in the plasminogen ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A single dose of ...

Hereditary angioedema (HAE) is a condition that causes repeated attacks of painful swelling. The swelling most often affects the skin, digestive tract, and upper airway (tongue, throat, and larynx).

Hereditary angioedema (HAE) is a genetic condition that causes bouts of swelling in the tissue under your skin. The uncomfortable swelling can happen in many different parts of your body, including ...

Hereditary angioedema (HAE) is a rare genetic disorder that causes swelling in different parts of the body. These attacks are often painful, unpredictable, and disfiguring. They can interfere with ...

Hereditary angioedema (HAE) is a rare genetic disease defined by recurrent attacks of edema, causing a substantial burden for patients, with morbidity, mortality, and reduced quality of life. This ...

Rapid swelling from hereditary angioedema can result from a variety of triggers. Doctors may use prophylactic medications to try and prevent these episodes, but managing stress and developing healthy ...

ORLANDO -- Long-term results from trials of new drugs for hereditary angioedema (HAE) continue to support efficacy and safety, researchers reported at the American College of Allergy, Asthma & ...